Enovis Corp key statistics and ratios

In fiscal 2025, Enovis Corp had return on equity of -58.5%, an operating margin of -50.0%, debt equal to 87.8% of equity and a current ratio of 2.02. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Enovis Corp: financial ratios, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJul 2026
Gross margin	35.4%	35.3%	34.6%	29.4%	31.0%	32.0%	31.2%	31.2%	34.7%	33.3%	42.1%	53.9%	54.5%	55.6%	58.0%	56.0%	59.8%	61.1%
Operating margin	7.5%	6.3%	3.7%	3.6%	9.7%	8.9%	7.7%	7.4%	7.0%	6.9%	6.1%	−5.9%	−4.4%	−4.6%	−3.8%	−36.8%	−50.0%	−45.1%
Net margin	4.5%	3.0%	0.7%	−1.6%	4.2%	8.5%	4.9%	4.0%	7.8%	6.4%	−15.9%	3.8%	5.0%	−0.9%	−1.9%	−39.2%	−52.7%	−48.0%
Free-cash-flow margin	5.3%	9.1%	6.1%	2.3%	6.9%	6.5%	6.8%	5.8%	7.7%	7.1%	0.2%	16.7%	17.7%	−10.3%	0.7%	−3.2%	0.9%	2.8%
Return on equity	11.0%	7.5%	2.2%	−6.1%	8.1%	13.9%	5.4%	4.3%	4.7%	4.1%	−15.7%	1.2%	1.8%	−0.3%	−1.0%	−27.6%	−58.5%	−74.3%
Return on assets	—	1.6%	0.4%	−1.8%	2.8%	5.7%	2.4%	2.0%	2.3%	2.1%	−7.5%	0.6%	0.9%	−0.2%	−0.8%	−17.9%	−27.7%	−29.0%
Asset turnover	—	0.53	0.66	1.08	0.66	0.67	0.49	0.49	0.30	0.33	0.48	0.15	0.18	0.24	0.39	0.46	0.53	0.60
Current ratio	—	1.68	1.46	1.80	1.54	1.62	1.55	1.64	1.89	1.63	1.64	1.68	2.25	1.41	2.43	2.17	2.02	1.98
Debt to equity	—	38.1%	58.9%	93.3%	59.9%	49.3%	46.5%	44.8%	30.6%	36.9%	67.7%	63.4%	45.4%	7.5%	14.0%	52.4%	87.8%	87.0%
Interest cover (operating income ÷ interest)	5.5x	5.1x	4.4x	1.5x	3.9x	8.0x	5.6x	7.8x	3.4x	3.1x	1.7x	n/m	n/m	n/m	n/m	n/m	n/m	n/m
Effective tax rate	26.6%	41.4%	77.2%	—	30.9%	−17.3%	18.9%	25.1%	5.1%	−31.9%	62.6%	—	—	—	—	—	—	—
R&D as % of revenue	1.1%	1.1%	0.8%	—	—	—	—	—	—	—	—	3.1%	3.4%	3.9%	4.4%	4.3%	5.4%	5.4%
SG&A as % of revenue	21.4%	24.6%	23.5%	23.2%	20.5%	21.9%	21.8%	21.9%	25.8%	25.0%	34.0%	46.0%	46.7%	49.4%	48.6%	48.7%	47.6%	47.1%
Capital spending as % of revenue	2.1%	2.3%	2.1%	2.1%	1.7%	1.8%	2.0%	2.0%	3.5%	3.2%	3.8%	10.2%	7.3%	6.7%	7.2%	8.6%	8.8%	9.0%
Free cash flow ÷ net income	116.4%	304.9%	930.1%	—	162.7%	76.8%	139.5%	143.4%	99.3%	111.8%	—	439.1%	351.5%	—	—	—	—	—
Dividends ÷ net income	—	1.3%	0.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Dividends and buybacks ÷ free cash flow	—	0.4%	0.0%	0.0%	0.0%	0.0%	11.7%	11.3%	0.0%	127.6%	0.0%	0.0%	—	—	0.0%	—	17.6%	—

US$ thousands unless shown otherwise. Fiscal quarters.

Enovis Corp: financial ratios, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Apr 2025	2025 Q2Jul 2025	2025 Q3Oct 2025	2025 Q4Dec 2025	2026 Q1Apr 2026	2026 Q2Jul 2026
Gross margin	56.7%	54.8%	59.5%	59.3%	59.9%	60.7%	62.0%	61.6%
Operating margin	−6.3%	−118.5%	−8.4%	−3.0%	−101.7%	−87.2%	1.1%	3.0%
Net margin	−6.2%	−125.4%	−10.0%	−6.5%	−104.1%	−90.4%	−1.5%	−0.2%
Free-cash-flow margin	0.5%	6.3%	−8.0%	0.6%	5.3%	5.6%	−4.9%	5.3%
Current ratio	2.27	2.17	2.55	2.25	2.22	2.02	2.04	1.98
Debt to equity	40.4%	51.9%	53.0%	54.1%	67.3%	87.1%	89.8%	87.0%
R&D as % of revenue	4.1%	4.3%	5.1%	5.4%	5.4%	5.4%	5.4%	5.4%
SG&A as % of revenue	49.5%	45.9%	48.1%	47.3%	48.0%	47.0%	48.0%	45.3%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 7 checks passed · July 3, 2026

What it owns · $3.8bn

Short-term assets $1.2bnLonger-term assets $2.6bn

What it owes, and who funded it · $3.8bn

Short-term liabilities $612mLonger-term liabilities $1.7bnShareholders' equity $1.5bn

Short-term assets cover short-term liabilities $1.2bn of assets due within a year against $612m of liabilities due within a year.
Short-term assets cover long-term liabilities $1.2bn short-term assets against $1.7bn of longer-dated liabilities.
More cash than debt $13m of cash against $1.3bn of debt.
Debt below 40% of shareholders' equity Debt is 87% of equity.
Debt burden no higher than five years ago Debt to equity moved from 45% to 87% over five years.
A year's operating cash flow covers at least 20% of debt $270m of operating cash flow against $1.3bn of debt.
Operating profit covers interest at least five times over Operating income of −$1.0bn against $34m of interest.

From Enovis Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

48 /100

Moderate moat

How hard Enovis's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

Returns on capital 3 / 20

Cash operating profit has been a median 4.2% of total assets over 10 years.
Pricing power 6 / 20

Gross margin has been a median 39.7%, moving by 12.6 percentage points (standard deviation) across 10 years.
Durability 10 / 20

Operating margin has been a median -1.9%; its worst year was -45.1%.
Cash conversion 8 / 20

Free cash flow was positive in 7 of 10 years, at a median 2.8% of revenue.
Discipline 20 / 20

The diluted share count fell 58.6% over five years; stock-based pay has been a median 1.0% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: ENOV vs TFX ENOV vs QDEL ENOV vs ITGR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Enovis Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Enovis Corp.